Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Over the last few years, there has been an increase in the use of glucagon-like peptide-1 receptor agonists ... that people ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The FBI has issued a warning about counterfeit versions of compounded weight loss drugs, which have been found to contain ...

FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...

Share on Pinterest Mounjaro, a tirzepatide drug prescribed ... in the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss. For this study, researchers analyzed ...